Photo taken from Vivek Subbiah/Twitter
Sep 7, 2023, 19:58
Vivek Subbiah: Super delighted to Join Dr. Stephen V Liu to share my thoughts…
Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on Twitter:
“Just in time for WCLC23 at The International Association for the Study of Lung Cancer for your post Labor Day motivation. Super delighted to Join Dr. Stephen V Liu to share my thoughts and vision for the future of clinical trials and dive into the world of
- Targeted therapies
- Phase1 trials
- Breaking down barriers to clinical trial enrollment
- New drugs
- Trial design and conduct
- Empowering fellows and new faculty and new oncologists to learn drug development and trial design to boost participation in clinical trials.”
For the podcast click here.
Source: Vivek Subbiah/Twitter
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 26, 2025, 06:10
Mar 26, 2025, 04:40
Mar 26, 2025, 03:22
Mar 26, 2025, 01:41
Mar 26, 2025, 01:17
Mar 26, 2025, 00:28
Mar 25, 2025, 20:07